FDA NDC Directory · JSON-LD · Markdown

EKTERLY

NDC 82928-300 · HUMAN PRESCRIPTION DRUG · TABLET

Generic namesebetralstat
Labeler / ManufacturerKalVista Pharmaceuticals Ltd
Marketing categoryNew Drug Application (innovator) · App NDA219301
Dosage form / routeTABLET · ORAL
Active ingredientsSEBETRALSTAT (300 mg/1)
Marketing started20250707
Package count1

External sources

Source: openFDA. Public-domain (CC0).